AGL 37.90 Decreased By ▼ -0.12 (-0.32%)
AIRLINK 213.50 Increased By ▲ 16.14 (8.18%)
BOP 9.86 Increased By ▲ 0.32 (3.35%)
CNERGY 6.40 Increased By ▲ 0.49 (8.29%)
DCL 9.22 Increased By ▲ 0.40 (4.54%)
DFML 37.51 Increased By ▲ 1.77 (4.95%)
DGKC 100.70 Increased By ▲ 3.84 (3.96%)
FCCL 35.95 Increased By ▲ 0.70 (1.99%)
FFBL 88.94 Increased By ▲ 6.64 (8.07%)
FFL 14.49 Increased By ▲ 1.32 (10.02%)
HUBC 133.76 Increased By ▲ 6.21 (4.87%)
HUMNL 13.70 Increased By ▲ 0.20 (1.48%)
KEL 5.63 Increased By ▲ 0.31 (5.83%)
KOSM 7.24 Increased By ▲ 0.24 (3.43%)
MLCF 46.12 Increased By ▲ 1.42 (3.18%)
NBP 61.17 Decreased By ▼ -0.25 (-0.41%)
OGDC 227.00 Increased By ▲ 12.33 (5.74%)
PAEL 41.40 Increased By ▲ 2.61 (6.73%)
PIBTL 8.61 Increased By ▲ 0.36 (4.36%)
PPL 202.40 Increased By ▲ 9.32 (4.83%)
PRL 39.94 Increased By ▲ 1.28 (3.31%)
PTC 27.72 Increased By ▲ 1.92 (7.44%)
SEARL 108.25 Increased By ▲ 4.65 (4.49%)
TELE 8.62 Increased By ▲ 0.32 (3.86%)
TOMCL 36.20 Increased By ▲ 1.20 (3.43%)
TPLP 14.24 Increased By ▲ 0.94 (7.07%)
TREET 24.38 Increased By ▲ 2.22 (10.02%)
TRG 61.15 Increased By ▲ 5.56 (10%)
UNITY 34.50 Increased By ▲ 1.53 (4.64%)
WTL 1.68 Increased By ▲ 0.08 (5%)
BR100 12,200 Increased By 473.7 (4.04%)
BR30 38,071 Increased By 1694.4 (4.66%)
KSE100 113,611 Increased By 4098 (3.74%)
KSE30 35,937 Increased By 1423.8 (4.13%)
Editorials

Gene-editing tech could make people immune to flu, HIV in future

Vaccines for viral infections like flu are difficult to develop, but thanks to new emerging gene-editing technology
Published February 16, 2019 Updated February 18, 2019

Vaccines for viral infections like flu are difficult to develop, but thanks to new emerging gene-editing technology, people could soon go immune to flu or even HIV.

Researchers at the Fred Hutchinson Cancer Research Center have developed a new technique for artificially creating advanced and longer-lasting antibodies by gene-editing the DNA of B cells – immune systems white blood cells responsible for creating antibodies.

As per Futurism, several traditional antibody treatments are only effective for a short time period; antibodies tend to break down rapidly, later requiring additional injections. According to scientists, their technique can ultimately allow doctors to overcome this hurdle since the new antibodies would only need to be injected once.

Chinese scientists clone gene-edited monkeys for disease research

The research published in the journal bioRxiv described that initial tests involved 15 mice and showed promising results, providing 82 days of protection against the respiratory syncytial virus (RSV) – a respiratory tract infection that can prove dangerous for children and adults both.

Moreover, according to New Scientist, despite gene-editing being a rapidly growing trend, scientists still need to prove the technique completely safe, which might take few years. But, according to the research, if the technology ever becomes treatment for humans in future, ‘thousands of hospital visits, disabilities, and death could be prevented each year’.

Copyright Business Recorder, 2019

Comments

Comments are closed.